GHRP-2 – 10mg

GHRP-2 (Growth Hormone Releasing Peptide 2) is a synthetic hexapeptide and potent agonist of the growth hormone secretagogue receptor (GHS-R1a). A ghrelin receptor that mediates endogenous growth hormone pulse stimulation from the pituitary gland. iLab Pharma’s formulation supplies 10mg as a lyophilized vial, preserving peptide structural integrity and potency across storage conditions until reconstitution; standard practice for GHRPs where aqueous stability at ambient temperature is limited and lyophilized storage maintains compound activity across extended research timelines.

GHRP-2’s mechanism of action operates through GHS-R1a receptor binding in the hypothalamus and pituitary, stimulating growth hormone secretion through two complementary pathways, directly stimulating pituitary somatotroph cells to release GH, and simultaneously suppressing somatostatin tone at the hypothalamic level, reducing the inhibitory signal that limits GH pulse amplitude. This dual mechanism produces a more robust GH secretory response than direct pituitary stimulation alone, and distinguishes GHRP-2 from GHRH analogues like Tesamorelin and CJC-1295 which operate exclusively through GHRH receptor stimulation. The combination of GHRP-2 with a GHRH analogue produces synergistic GH secretion that exceeds either compound administered alone. Its a well documented research interaction that makes GHRP-2 one of the most frequently studied compounds in GH secretagogue combination research.

GHRP-2 is one of the most potent GHRPs in the research literature, with documented GH stimulation activity superior to GHRP-6 at equivalent doses attributed to GHRP-2’s stronger GHS-R1a binding affinity and reduced appetite stimulating activity compared to its predecessor. This potency and receptor affinity profile makes GHRP-2 a frequently selected reference compound in comparative GHRP research examining dose response relationships across the GHS-R1a agonist peptide family. CSD stocks GHRP-2 alongside Tesamorelin in the growth hormone secretagogue range, giving researchers access to both GHS-R1a agonist and GHRH receptor agonist mechanisms from a single verified Canadian supplier for complete GH axis stimulation research coverage.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s GHRP-2 meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside CJC-1295 and Ipamorelin in comparative GH secretagogue combination and GHS-R1a agonist studies. Browse CSD’s full peptide range for complete sourcing.